$PTGX
BEARISH2022-04-13By horizon✓ hit-2.9%
1d
✗ +2.4%
5d
…
21d
✓ -2.9%
Original post
DRUGS · 2022-04-13
Wow weird. $PTGX gets breakthrough therapy designation rescinded for rusfertide. Looks to be due to finding 3 skin cancers after re-enrollment after clinical hold lifted... Oh and PN-943 in 'first half' of 2Q22. https://t.co/iekLPyeXMn
View on X ↗